Thermal cycling hyperthermia sensitizes non-small cell lung cancer A549 cells to EGFR-tyrosine kinase inhibitor Erlotinib
G.-B. Lin, W.-T. Chen, Y.-Y. Kuo, H.-H. Liu, Y.-M. Chen, S.-J. Leu, C.-Y. Chao
This study shows that thermal cycling hyperthermia enhances the effectiveness of Erlotinib in A549 NSCLC cells by reducing IC50 and inducing cell cycle arrest.
bioRxiv · May 3, 2022Cancer Biology